What does the Cohance Lifesciences Limited (COHANCE) stock page cover?

Cohance Lifesciences Limited on Anvest includes delayed price context, valuation ratios, a one-year price range, and section-level research data when available.

What are the current headline metrics for COHANCE?

Cohance Lifesciences Limited is currently shown with a delayed price near ₹444.3, P/E 159.82.

Does the COHANCE page provide investment advice?

No. The COHANCE page is built for research, comparison, and planning. It does not publish buy, sell, or hold recommendations.

Stocks›Healthcare

Watch Alert

Cohance Lifesciences Limited

COHANCE · NSE · Healthcare · As of 30 Oct 2026Delayed / Sandbox EOD Data

₹444.30

−₹37.05 (−7.70%)(1D)

₹266.7052 Week Range₹779.45

Anvest Score

31/100

Valuation

0/100

Quality

23/100

Growth

7/100

Health

99/100

Momentum

45/100

Valuation
0
Quality
23
Growth
7
Health
99
Momentum
45

Loading company profile…

More Page Context

Research at a glance

Cohance Lifesciences Limited with delayed price, financials, ownership context, and peer links.

Latest price

₹444.3

Market cap

₹16,998 Cr

P/E ratio

159.82

P/B ratio

4.35

Dividend yield

Not available

ROE

Not available

RSI 14

45.1

1Y return

Not available